SOFIE Biosciences Expands PET Radiopharmaceuticals Network with Illinois Facility

• SOFIE Biosciences has opened a PET manufacturing and radiopharmacy facility in Decatur, Illinois, expanding its service across Illinois, Missouri, and Indiana.

• Patient dose delivery is set to begin this week, reinforcing the company’s commitment to molecular imaging and nuclear medicine.

SOFIE Biosciences has expanded its radiopharmaceutical network with the opening of a new PET manufacturing and radiopharmacy facility in Decatur, Illinois. The facility strengthens SOFIE’s production and distribution capabilities, enhancing service across Illinois, Missouri, and Indiana.

The newly acquired site will operate under SOFIE Biosciences’ established quality and compliance standards while ensuring continued service for existing customers. The company has announced that patient dose delivery will commence this week.

Mike Parisi, Vice President, Sales & Marketing at SOFIE Biosciences, highlighted the significance of this expansion. “We are excited to integrate this facility into our growing network. This expansion enhances our ability to deliver high-quality PET radiopharmaceuticals to healthcare providers and patients across the region, supporting better diagnostic and therapeutic outcomes.”